chevron_leftBack
As of 13 June 2026, PharmChem, Inc. has a market cap of $21.95M USD, ranking #36462 globally and #4951 in the United States.
It ranks #3273 in the Healthcare sector, and #693 in the Medical Devices industry.
Key Stats
Market Cap
$21.95MUSD
Revenue (TTM)
$25.73MUSD
Net Income (TTM)
-$2.04MUSD
Profit Margin
-7.9%
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Devices
CEO
Thompson Clark
open_in_new
Employees
170
Founded
2000
Website
pharmchek.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 0.3% | 0.3% | 1.6% | 1.4% | 14% | 15% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
PCHM
PharmChem Inc
ISIN: US7171331025
Shares Out.:
Shares Outstanding:
5.853M1
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
3.75 USD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About PharmChem, Inc.
PharmChem, Inc. provides PharmChek Sweat Patch that is used to detect drugs of abuse. Its PharmChek Sweat Patch uses sweat as the source and offers alternative to urine testing for cocaine, opiates, amphetamines, PCP, and marijuana. The company was incorporated in 2000 and is based in Fort Worth, Texas.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: TMO
|
$173.27B
789K%
|
25.8
|
|
NASDAQ: ISRG
|
$160.73B
732K%
|
56.7
|
|
NYSE: ABT
|
$159.07B
725K%
|
25.6
|
|
NYSE: DHR
|
$126.55B
576K%
|
34.7
|
|
NYSE: SYK
|
$120.69B
550K%
|
38.3
|
|
NYSE: BSX
|
$84.93B
387K%
|
24.5
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: MDT
|
$101.9B
464K%
|
22.2
|
|
EPA: EL
|
$97.46B
444K%
84.32B EUR
|
36.7
|
|
TSE: 7741
|
$61.41B
280K%
9.83T JPY
|
40.0
|
|
XETRA: SHL
|
$45.47B
207K%
39.34B EUR
|
18.7
|
|
SIX: ALC
|
$36.38B
166K%
28.99B CHF
|
37.9
|
|
|
$30.06B
137K%
203.66B CNY
|
26.0
|
chevron_leftBack